Answers are grounded in this paper and cite their sources.
Evaluate the efficacy and safety of two dosing regimens of continuous subcutaneous L-dopa/carbidopa (ND0612H).
No takes yet. Share an insight, caveat, or question.
Olanow et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: